Drug Profile
Research programme: cancer therapeutics - Chimerix
Latest Information Update: 16 Oct 2007
Price :
$50
*
At a glance
- Originator Chimerix
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 May 2006 Early research in Cancer in USA (unspecified route)